Buscar
Mostrando ítems 1-10 de 36
Chronic cerebral hypoperfusion alters amyloid-β peptide pools leading to cerebral amyloid angiopathy, microinfarcts and haemorrhages in Tg-SwDI mice
(Portland Press Ltd., 2017)
Cerebral hypoperfusion is an early feature of Alzheimer's disease (AD) that influences the progression from mild cognitive impairment to dementia. Understanding the mechanism is of critical importance in the search for new ...
In Vivo Studies of Protein Misfolding and Neurodegeneration Induced by Metabolic Syndrome Relative to Chronic Cerebral Hypoperfusion: A Critical Review
(IntechOpen, 2020)
Metabolic syndrome (MetS) leads to microvascular dysfunction and chronic cerebral hypoperfusion (CCH) in an insidious way. Clinical evidence and several rodent models have contributed to determining the neurodegenerative ...
Neuroprotection targeting protein misfolding on chronic cerebral hypoperfusion in the context of metabolic syndrome
(Frontiers Media S.A., 2018-05)
Metabolic syndrome (MetS) is a cluster of risk factors that lead to microvascular dysfunction and chronic cerebral hypoperfusion (CCH). Long-standing reduction in oxygen and energy supply leads to brain hypoxia and protein ...
Editorial: Neurological comorbidity in metabolic syndrome
(Frontiers Media SA, 2024)
Efeitos da Atorvastatina (Citalor®) sobre as sequelas neurohistológicas e comportamentais induzidas por hipoperfusão cerebral crônica em ratos de meia-idadeEffects of Atorvastatin (Citalor®) on the behavioral and neurohistological sequelae after chronic cerebral hypoperfusion in middle-aged rats
(Universidade Estadual de MaringáBrasilDepartamento de Farmacologia e TerapêuticaPrograma de Pós-Graduação em Ciências FarmacêuticasUEMMaringá, PRCentro de Ciências da Saúde, 2018)
Neuroprotection targeting protein misfolding on chronic cerebral hypoperfusion in the context of metabolic syndrome
(Frontiers Media S.A., 2018)